AGT Biosciences changes name to Chemgenex

By Melissa Trudinger
Tuesday, 29 June, 2004

AGT Biosciences has completed the last step in its merger with ChemGenex Therapeutics with the official name change of the company going through. Approval by AGT shareholders was obtained last week at an EGM.

From today, the company is to be known as ChemGenex Pharmaceuticals and will carry the ASX stock symbol 'CXS'.

argenx and Monash University partner against autoimmune diseases

To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...

Archer completes potassium sensing alpha prototype

Quantum technology company Archer Materials Limited has developed an early Biochip prototype...

Farm animals and aquaculture cryopreservation partnership announced

Vitrafy Life Sciences Limited has announced that it has entered a 12-month exclusive agreement...

Content from other channels on our network

Seeing with AI: flexible navigation in dynamic environments with Visual SLAM

BioCarbon secures funding to commercialise biochar coke

Schneider Electric moves towards SDA with new DCS

Collie home to WA’s largest state‍-‍owned battery

Endress+Hauser acquires particle analysis specialist

How do different types of pain influence empathy?

St Vincent's Hospital Sydney junior doctors class action underway

Hospital waiting times remain high, new Productivity Commission data reveals

From vision to vigilance: building a secure digital future for health care

The Emergency Department Access & Performance Conference

Feed supplement wins at 2026 SEAL Awards

NSW to exceed energy storage targets

Ferrocene could be key to next-gen grid-storage batteries

A matter of influence: getting over the 'ick' with recycled water

How sustainability is shaping network strategy